VSMART

On 9 May 2019, researchers from Woolcock Vietnam National TB Program gathered in the Vietnam National Lung Hospital to prepare an implementation plan for the new community-based parallel group randomised controlled trial - VSMART.

The study, funded by NAFOSTED and NHMRC, aims to evaluate effectiveness of an innovative mHealth adverse event application on treatment success among multi drug resistant TB patients.